top
Search terms
Results 61 - 70 of 216 - ordered by :
Pages: 1 ... 4 5 6 7 8 9 10 ... 22
Escardio

A secondary analysis of the FOURIER trial has identified a monotonic relationship between LDL cholesterol and major cardiovascular outcomes with no safety concerns even at low LDL cholesterol ...

Date : 29/08/2017
Escardio

The results, which were a key highlight of yesterday’s Hot Line: Late-Breaking Clinical Trial session, offered a “resounding ‘no’ to oxygen therapy,” according to ...

Date : 29/08/2017
Escardio

Pharmacoinvasive treatment “could be beneficial” for STEMI patients Doctor Ben He (Shanghai, China) presented data on behalf of the EARLY-MYO investigators indicating that in STEMI ...

Date : 28/08/2017
Escardio

Professor Michael Haude (Medical Clinic I Lukas Hospital, Neuss, Germany) explores recent evidence regarding the use of of PCI versus coronary artery bypass grafting (CABG) for coronary ...

Date : 28/08/2017
Escardio

Patients with stable atherosclerotic vascular disease who take rivaroxaban (2.5mg twice daily) plus aspirin (100mg once daily) have better cardiovascular outcomes than those who take aspirin alone, ...

Date : 28/08/2017
Escardio

Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research presented today in a Hot Line LBCT Session at ESC Congress (1) and published in ...

Date : 28/08/2017
Escardio

Existing antithrombotic therapy during and after PCI consists of the mandatory use of aspirin, intravenous (IV) anticoagulation (such as unfractionated heparin, low molecular weight heparin, or ...

Date : 28/08/2017
Escardio

Formerly considered diuretics, mineralocorticoid receptor antagonists (MRAs) “are still underused in routine clinical practice, but our data may hopefully contribute to expanded use of these ...

Date : 28/08/2017
Escardio

The long-term follow-up of patients in the NIPPON (NoborI dual antiplatelet therapy as aPPrOpriate DuratioN) study is presented today at ESC Congress 2017. “These findings support and ...

Date : 28/08/2017
Escardio

The findings, presented at ESC Congress today and published in the Lancet, “suggest that a lower LDL-C target - far below current guidelines - can safely be considered to further reduce the ...

Date : 28/08/2017